While the study identifies ADORA2A as a key target through molecular docking and pharmacological validation, the specific mechanism by which parthenolide modulates ADORA2A signaling remains unclear. Understanding whether parthenolide acts as an agonist, antagonist, or allosteric modulator is critical for therapeutic development. Gap type: unexplained_observation Source paper: Parthenolide inhibits methamphetamine-induced depressive-like behavior by targeting ADORA2A. (2026, Phytomedicine : international journal of phytotherapy and phytopharmacology, PMID:41795299)
Landscape Summary: How does parthenolide specifically modulate ADORA2A signaling to produce antidepressant effects? is a 0.87 priority gap in neuropharmacology. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.
Colonna, Sevlever, et al. (TREM2 biology)
How does parthenolide specifically modulate ADORA2A signaling to produce antidepressant effects? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: